MRI system significantly improves prostate cancer detection and efficiency. Find out how ProAI boosts accuracy and reduces ...
In this episode, Nicolas Girard discusses the latest developments in non-small cell lung cancer (NSCLC), with a focus on new ...
Phase 3b WAYFINDER data show tezepelumab oral corticosteroid reduction in severe asthma, with nearly 90 percent reaching 5 mg ...
Over half of patients with severe asthma discontinued oral corticosteroids while maintaining disease control, major study ...
A simple blood test analysed by artificial intelligence could revolutionise early detection of primary vitreoretinal lymphoma ...
The following highlights showcase key research presented at the European Society for Medical Oncology (ESMO) 2025 Congress.
Sexually transmitted infections (STI) have a disproportionately high prevalence in individuals in custody and persons with ...
Standalone MRI caught most breast cancer cases missed by AI, highlighting a key safety net for dense breasts. Find out more.
Over the past two decades, thoracic oncology has undergone a profound transformation, moving from limited chemotherapy ...
Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...
EMJ's latest Oncology Journal is now available, covering everything you need to know from ESMO 2025 and beyond. Inside, ...
Congress 2025 took place in Berlin, Germany, a dynamic epicentre known for its blend of innovation, culture, and historical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results